focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShaftesbury Capital Regulatory News (SHC)

Share Price Information for Shaftesbury Capital (SHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 141.20
Bid: 141.20
Ask: 141.50
Change: 0.20 (0.14%)
Spread: 0.30 (0.212%)
Open: 138.40
High: 141.60
Low: 138.40
Prev. Close: 141.00
SHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of 25-31 James Street, Covent Garden

11 Mar 2024 07:00

RNS Number : 2507G
Shaftesbury Capital PLC
11 March 2024
 

Press Release

11 March 2024

Acquisition of 25-31 James Street, Covent Garden

Shaftesbury Capital PLC ("Shaftesbury Capital") is pleased to announce that it has completed the acquisition of the freehold interests in 25-31 James Street, Covent Garden for £75.1 million (before costs).

The properties have a contracted rent of £3.9 million and comprise 21,000 square feet of lettable area, including 12,000 square feet of retail and 9,000 square feet of residential and office accommodation.

This acquisition presents asset management and rental growth opportunities as well as complementing our existing ownership on James Street, a prime retail street and key gateway into the Covent Garden Piazza. The acquisition follows recent disposals totalling £145 million, 8 per cent ahead of valuation, and recycles capital towards target assets.

Shaftesbury Capital continues to maintain access to liquidity through cash and undrawn facilities. On a pro forma basis, liquidity following this acquisition is £467 million.

 

Enquiries:

Shaftesbury Capital PLC

+44 (0)20 3214 9150

Ian Hawksworth

Chief Executive

 

Situl Jobanputra

Chief Financial Officer

Michelle McGrath

Executive Director

Sarah Corbett

Director of Commercial Finance and Investor Relations

Media enquiries:

UK: Hudson Sandler

UK: RMS Partners

Michael Sandler

Simon Courtenay

+44 (0)20 7796 4133

+44 (0)20 3735 6551

SA: Instinctif

Frederic Cornet

+27 (0)11 447 3030

 

About Shaftesbury Capital

Shaftesbury Capital PLC ("Shaftesbury Capital") is the leading central London mixed-use REIT and is a constituent of the FTSE-250 Index. Our property portfolio, valued at £4.8 billion at December 2023, extends to 2.9 million square feet of lettable space across the most vibrant areas of London's West End. With a diverse mix of shops, restaurants, cafés, bars, residential and offices, our destinations include the high footfall, thriving neighbourhoods of Covent Garden, Carnaby, Soho and Chinatown, together with holdings in Fitzrovia. Our properties are close to the main West End Underground stations and transport hubs for the Elizabeth Line. Shaftesbury Capital shares are listed on the London Stock Exchange ("LSE") (primary) and the Johannesburg Stock Exchange ("JSE") (secondary) and the A2X (secondary).

Our purpose

Investing to create thriving destinations in London's West End where people enjoy visiting, working, and living.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQGPUBAWUPCPGU
12
Date   Source Headline
16th Apr 202411:30 amRNSAdditional Listing
16th Apr 20249:30 amRNS2023 Final Dividend - Exchange Rate
2nd Apr 202411:30 amRNSHolding(s) in Company
28th Mar 202410:45 amRNSHolding(s) in Company
21st Mar 20242:00 pmRNSDirector/PDMR Shareholding
18th Mar 202411:15 amRNSBlock listing Interim Review
14th Mar 20241:45 pmRNSPublication of 2023 Annual Report and AGM notice
11th Mar 20247:00 amRNSAcquisition of 25-31 James Street, Covent Garden
6th Mar 20247:00 amRNSPost-offer Intention Statements
5th Mar 20242:35 pmRNSNotice to Bondholders
5th Mar 20242:30 pmRNSHolding(s) in Company
1st Mar 202412:30 pmRNSHolding(s) in Company
29th Feb 20242:30 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSFinal Results
7th Feb 202411:30 amRNSNotification of new external directorship
30th Jan 202410:00 amRNSNotice of Results
12th Jan 20241:45 pmRNSHolding(s) in Company
18th Dec 20237:00 amRNSDirectorate Change
12th Dec 20237:00 amRNSDirectorate Change
5th Dec 20237:30 amRNSNew medium-term bank loan of £300 million
28th Nov 20231:00 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSInvestor event and trading update
21st Nov 202310:30 amRNSNotification of new external directorship
21st Nov 202310:20 amRNSHolding(s) in Company
20th Nov 202311:20 amRNSHolding(s) in Company
17th Nov 20232:30 pmRNSHolding(s) in Company
15th Nov 20231:30 pmRNSHolding(s) in Company
14th Nov 20231:30 pmRNSDirector/PDMR Shareholding
6th Nov 20239:50 amRNSHolding(s) in Company
1st Nov 20238:55 amRNSHolding(s) in Company
30th Oct 20233:30 pmRNSHolding(s) in Company
12th Oct 20233:20 pmRNSHolding(s) in Company
25th Sep 202311:30 amRNSHolding(s) in Company
19th Sep 20231:00 pmRNSHolding(s) in Company
18th Sep 20234:15 pmRNSNotice to Bondholders
18th Sep 202310:00 amRNSBlock listing Interim Review
13th Sep 20231:15 pmRNSHolding(s) in Company
7th Sep 20231:00 pmRNSHolding(s) in Company
15th Aug 20239:00 amRNS2023 Interim Dividend - Exchange Rate
14th Aug 20237:00 amRNSNew long-term loan facility of £200 million
8th Aug 202310:15 amRNSNotice to Bondholders
3rd Aug 20237:00 amRNSHalf-year Report
15th Jun 20233:45 pmRNSResult of AGM
14th Jun 20237:00 amRNSTrading Update
28th Apr 20239:50 amRNSBlock listing Interim Review
18th Apr 202312:45 pmRNSBonds Redemption and Utilisation of Loan Facility
31st Mar 20239:00 amRNSTotal Voting Rights
28th Mar 20234:00 pmRNSNotice of AGM and Scrip Dividend Scheme
24th Mar 20233:40 pmRNSDirector/PDMR Shareholding
24th Mar 20233:00 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.